Investigating the effects and side effects of bupropion in multiple sclerosis patients
Phase 2
- Conditions
- Quality of life.Multiple sclerosis
- Registration Number
- IRCT20190325043107N48
- Lead Sponsor
- Tabriz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
Definitive diagnosis of multiple sclerosis based on MacDonald criteria 2017 version
EDSS value smaller than four
Exclusion Criteria
Taking drugs that have a reducing or intensifying effect on fatigue, such as dalfampridine, modafinil, antidepressants and other psychiatric drugs.
Using other auxiliary methods such as herbal medicines, antidepressants, yoga, unnecessary supplements, addiction or drug use
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method